The Role of Cytology in Molecular Testing and Personalized Medicine in Lung Cancer: A Clinical Perspective

Cancer cytopathology - United States
doi 10.1002/cncy.22085
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Improving Molecular Testing and Personalized Medicine in Non-Small-Cell Lung Cancer in Ontario

Current Oncology
Oncology
2017English

Role of PET/CT for Precision Medicine in Lung Cancer: Perspective of the Society of Nuclear Medicine and Molecular Imaging

Translational Lung Cancer Research
Oncology
2017English

Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2016English

Immunocytochemistry for Predictive Biomarker Testing in Lung Cancer Cytology

Cancer cytopathology
Cancer ResearchOncology
2019English

Genomics and Personalized Medicine: A Perspective

Personalized Medicine
MedicineMolecular MedicinePharmacology
2009English

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2016English

Is There a Role of Eastern Europe in Cancer Biomarkers for Personalized Cancer Medicine?

Cancer Biomarkers
MedicineCancer ResearchOncologyGenetics
2014English

The Cytopathologist's Expanding Role in the 2018 Updated Molecular Testing Guidelines for Lung Cancer

Cancer cytopathology
Cancer ResearchOncology
2018English

The Role of Personalized Medicine in Metastatic Colorectal Cancer: An Evolving Landscape

Therapeutic Advances in Gastroenterology
Gastroenterology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy